RESUMEN
CREB-binding proteins (CBP) and p300 are essential transcriptional coactivators for a large number of regulated DNA-binding transcription factors, including CREB, nuclear receptors, and STATs. CBP and p300 function in part by mediating the assembly of multiprotein complexes that contain additional cofactors such as p300/CBP interacting protein (p/CIP), a member of the p160/SRC family of coactivators, and the p300/CBP associated factor p/CAF. In addition to serving as molecular scaffolds, CBP and p300 each possess intrinsic acetyltransferase activities that are required for their function as coactivators. Here we report that the adenovirus E1A protein inhibits the acetyltransferase activity of CBP on binding to the C/H3 domain, whereas binding of CREB, or a CREB/E1A fusion protein to the KIX domain, fails to inhibit CBP acetyltransferase activity. Surprisingly, p/CIP can either inhibit or stimulate CBP acetyltransferase activity depending on the specific substrate evaluated and the functional domains present in the p/CIP protein. While the CBP interaction domain of p/CIP inhibits acetylation of histones H3, H4, or high mobility group by CBP, it enhances acetylation of other substrates, such as Pit-1. These observations suggest that the acetyltransferase activities of CBP/p300 and p/CAF can be differentially modulated by factors binding to distinct regions of CBP/p300. Because these interactions are likely to result in differential effects on the coactivator functions of CBP/p300 for different classes of transcription factors, regulation of CBP/p300 acetyltransferase activity may represent a mechanism for integration of diverse signaling pathways.
Asunto(s)
Acetiltransferasas/metabolismo , Proteínas E1A de Adenovirus/metabolismo , Proteínas Nucleares/metabolismo , Transactivadores/metabolismo , Acetilación , Animales , Sitios de Unión , Proteína de Unión a CREB , Línea Celular , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Fibroblastos , Histonas/metabolismo , Cinética , Ratas , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes/metabolismo , Especificidad por Sustrato , TransfecciónRESUMEN
POU-domain proteins, such as the pituitary-specific factor Pit-1, are members of the homeodomain family of proteins which are important in development and homeostasis, acting constitutively or in response to signal-transduction pathways to either repress or activate the expression of specific genes. Here we show that whereas homeodomain-containing repressors such as Rpx2 seem to recruit only a co-repressor complex, the activity of Pit-1 is determined by a regulated balance between a co-repressor complex that contains N-CoR/SMRT, mSin3A/B and histone deacetylases, and a co-activator complex that includes the CREB-binding protein (CBP) and p/CAF. Activation of Pit-1 by cyclic AMP or growth factors depends on distinct amino- and carboxy-terminal domains of CBP, respectively. Furthermore, the histone acetyltransferase functions of CBP or p/CAF are required for Pit-1 function that is stimulated by cyclic AMP or growth factors, respectively. These data show that there is a switch in specific requirements for histone acetyltransferases and CBP domains in mediating the effects of different signal-transduction pathways on specific DNA-bound transcription factors.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , Proteínas de Homeodominio/metabolismo , Transducción de Señal , Factores de Transcripción/metabolismo , Acetiltransferasas/metabolismo , Unión Competitiva , Proteína de Unión a CREB , Proteínas de Ciclo Celular/metabolismo , Línea Celular , AMP Cíclico/metabolismo , Sustancias de Crecimiento/metabolismo , Células HeLa , Histona Acetiltransferasas , Humanos , Proteínas Nucleares/metabolismo , Co-Represor 1 de Receptor Nuclear , Fosforilación , Unión Proteica , Receptores de Estrógenos/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Represoras/metabolismo , Transactivadores/metabolismo , Factor de Transcripción Pit-1 , Factores de Transcripción p300-CBPRESUMEN
Aspergillus fumigatus produces a variety of extracellular proteinases that are believed to be virulence factors towards Aspergillus-related lung disease. Among Aspergillus proteinases, the serine proteinase is thought to play a major virulent role because of its widespread production. Nevertheless, evidence of direct pulmonary injury caused by the A. fumigatus serine proteinase is still lacking. The purpose of our work was: (1) to provide evidence for a pivotal role of A. fumigatus serine proteinase in producing lung injury in an animal model, and (2) to investigate the broadness of the substrate specificity of the proteinase towards extracellular matrix components. To achieve this aim, the proteinase from an A. fumigatus strain isolated from human airways was purified by a four-step procedure, including cation exchange and hydrophobic interaction. High-performance capillary electrophoresis, SDS-PAGE, determination of K(m) towards synthetic substrates, and inhibitory studies were used to further characterize the A. fumigatus serine proteinase. With reference to extracellular matrix components, the A. fumigatus serine proteinase was shown to degrade human lung elastin at a higher rate than an equimolar amount of human neutrophil elastase. Human lung collagen, type I and type III collagens, as well as fibronectin, were quickly digested by the A. fumigatus serine proteinase. Finally, mice intratracheally injected with the proteinase showed a significant degree of lower respiratory tract destruction. We conclude that the A. fumigatus serine proteinase is capable per se of hydrolyzing the major structural barriers of the lung.
Asunto(s)
Aspergillus fumigatus/enzimología , Proteínas de la Matriz Extracelular/metabolismo , Matriz Extracelular/efectos de los fármacos , Enfermedades Pulmonares/inducido químicamente , Pulmón/efectos de los fármacos , Serina Endopeptidasas/farmacología , Animales , Colágeno/metabolismo , Modelos Animales de Enfermedad , Elastina/metabolismo , Electroforesis Capilar , Electroforesis en Gel de Poliacrilamida , Fibronectinas/metabolismo , Humanos , Pulmón/metabolismo , Pulmón/patología , Enfermedades Pulmonares/metabolismo , Enfermedades Pulmonares/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Serina Endopeptidasas/aislamiento & purificación , Especificidad por SustratoRESUMEN
Different classes of mammalian transcription factors-nuclear receptors, cyclic adenosine 3',5'-monophosphate-regulated enhancer binding protein (CREB), and signal transducer and activator of transcription-1 (STAT-1)-functionally require distinct components of the coactivator complex, including CREB-binding protein (CBP/p300), nuclear receptor coactivators (NCoAs), and p300/CBP-associated factor (p/CAF), based on their platform or assembly properties. Retinoic acid receptor, CREB, and STAT-1 also require different histone acetyltransferase (HAT) activities to activate transcription. Thus, transcription factor-specific differences in configuration and content of the coactivator complex dictate requirements for specific acetyltransferase activities, providing an explanation, at least in part, for the presence of multiple HAT components of the complex.
Asunto(s)
Acetiltransferasas/metabolismo , Proteínas de Ciclo Celular/metabolismo , Proteínas Nucleares/metabolismo , Proteínas de Saccharomyces cerevisiae , Factores de Transcripción/metabolismo , Transcripción Genética , Acetiltransferasas/genética , Proteína de Unión a CREB , Proteínas de Ciclo Celular/genética , AMP Cíclico/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica , Células HeLa , Histona Acetiltransferasas , Humanos , Ligandos , Mutación , Co-Represor 1 de Receptor Nuclear , Coactivador 1 de Receptor Nuclear , Coactivador 3 de Receptor Nuclear , Regiones Promotoras Genéticas , Receptores de Ácido Retinoico/metabolismo , Proteínas Represoras/metabolismo , Factor de Transcripción STAT1 , Transactivadores/metabolismo , Factores de Transcripción/genética , Activación Transcripcional , Factores de Transcripción p300-CBPRESUMEN
We report that interferon gamma (IFN-gamma) inhibits transcription of the macrophage scavenger receptor gene by antagonizing the Ras-dependent activities of AP-1 and cooperating ets domain transcription factors, apparently as a result of competition between AP-1/ets factors and activated STAT1 for limiting amounts of CBP and p300. Consistent with this model, STAT1 alpha interacts directly with CBP in cells, and microinjection of anti-CBP and anti-p300 antibodies blocks transcriptional responses to IFN-gamma. Cells lacking STAT1 fail to inhibit AP-1/ets activity, and overexpression of CBP both potentiates IFN-gamma-dependent transcription and relieves AP-1/ets repression. Thus, CBP and p300 integrate both positive and negative effects of IFN-gamma on gene expression by serving as essential coactivators of STAT1 alpha, modulating gene-specific responses to simultaneous activation of two or more signal transduction pathways.
Asunto(s)
Acetiltransferasas , Interferón gamma/farmacología , Factor Estimulante de Colonias de Macrófagos/farmacología , Macrófagos/efectos de los fármacos , Proteínas de la Membrana , Receptores Inmunológicos/genética , Receptores de Lipoproteína , Transducción de Señal , Animales , Proteína de Unión a CREB , Proteínas de Ciclo Celular/metabolismo , Proteínas de Unión al ADN/metabolismo , Antagonismo de Drogas , Histona Acetiltransferasas , Humanos , Ratones , Ratones Transgénicos , Proteínas Nucleares/metabolismo , Receptores Depuradores , Factor de Transcripción STAT1 , Receptores Depuradores de Clase B , Transactivadores/metabolismo , Factor de Transcripción AP-1/metabolismo , Factores de Transcripción/metabolismo , Transcripción Genética , Factores de Transcripción p300-CBPRESUMEN
Both astrocytes in the central nervous system and fibroblasts in somatic tissues are not only the major sources of extracellular matrix components but also of matrix metalloproteinases (MMPs), a family of enzymes directly involved in extracellular matrix breakdown. We have analyzed the regulation of the expression of MMPs and TIMPs (tissue inhibitors of metalloproteinases) in human primary astrocytes stimulated with oncostatin M (OSM) and other extracellular mediators in comparison with normal human dermal fibroblasts. It was found that OSM induced/enhanced transcription of MMP-1 (interstitial collagenase) and MMP-3 (stromelysin 1) in astrocytes, and MMP-1, MMP-9 (gelatinase B), and TIMP-1 in fibroblasts. Analysis of the signal transduction leading to activation of the MMP-1 gene revealed the presence of an OSM-responsive element (OMRE) encompassing the AP-1 binding site and the signal transducer and activator of transcription (STAT) binding element, which mediate activation by OSM. OMRE is also present in the TIMP-1 gene promoter and, although there are some differences in these two motifs, both appear to be targets for the simultaneous action of OSM-induced nuclear effectors. The induced enhancement of transcription by synergistically acting AP-1 and STAT binding elements in response to OSM is Raf-dependent. Cross-talk between the mitogen-activated protein kinase and JAK-STAT pathways is required to achieve maximal induction of the OMRE-driven transcription by OSM.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , Regulación Enzimológica de la Expresión Génica , Glicoproteínas/genética , Péptidos/genética , Proteínas Tirosina Quinasas/metabolismo , Transducción de Señal , Transactivadores/metabolismo , Secuencia de Bases , Northern Blotting , Electroforesis en Gel de Poliacrilamida , Glicoproteínas/metabolismo , Humanos , Interferón gamma/metabolismo , Interleucina-6/metabolismo , Janus Quinasa 1 , Modelos Biológicos , Datos de Secuencia Molecular , Oncostatina M , Péptidos/metabolismo , Factor de Transcripción STAT1 , Inhibidores Tisulares de Metaloproteinasas , Factor de Transcripción AP-1/metabolismoRESUMEN
The crystal structure of human neutrophil cathepsin G, complexed with the peptidyl phosphonate inhibitor Suc-Val-Pro-PheP-(OPh)2, has been determined to a resolution of 1.8 A using Patterson search techniques. The cathepsin G structure shows the polypeptide fold characteristic of trypsin-like serine proteinases and is especially similar to rat mast cell proteinase II. Unique to cathepsin G, however, is the presence of Glu226 (chymotrypsinogen numbering), which is situated at the bottom of the S1 specificity pocket, dividing it into two compartments. For this reason, the benzyl side chain of the inhibitor PheP residue does not fully occupy the pocket but is, instead, located at its entrance. Its positively charged equatorial edge is involved in a favourable electrostatic interaction with the negatively charged carboxylate group of Glu226. Arrangement of this Glu226 carboxylate would also allow accommodation of a Lys side chain in this S1 pocket, in agreement with the recently observed cathepsin G preference for Lys and Phe at P1. The cathepsin G complex with the covalently bound phosphonate inhibitor mimics a tetrahedral substrate intermediate. A comparison of the Arg surface distributions of cathepsin G, leukocyte elastase and rat mast cell protease II shows no simple common recognition pattern for a mannose-6-phosphate receptor-independent targeting mechanism for sorting of these granular proteinases.
Asunto(s)
Catepsinas/química , Oligopéptidos/metabolismo , Serina Endopeptidasas/química , Secuencia de Aminoácidos , Animales , Sitios de Unión , Catepsina G , Catepsinas/metabolismo , Cristalografía por Rayos X , Humanos , Elastasa de Leucocito/química , Elastasa de Leucocito/metabolismo , Metaloendopeptidasas/química , Metaloendopeptidasas/metabolismo , Modelos Moleculares , Datos de Secuencia Molecular , Neutrófilos/química , Oligopéptidos/química , Conformación Proteica , Ratas , Receptor IGF Tipo 2/química , Receptor IGF Tipo 2/metabolismo , Serina Endopeptidasas/metabolismo , EstereoisomerismoRESUMEN
The Semi-alkaline proteinase (Seaprose) from Aspergillus melleus has been tested for its ability to either inactivate or form complexes with three human plasma proteinase inhibitors, alpha-2-macroglobulin, alpha-1-antichymotrypsin and alpha-1-proteinase inhibitor. alpha-2-Macroglobulin was found to inhibit Seaprose, with two mol of enzyme being complexed per mol of inhibitor. However, alpha-1-proteinase inhibitor was rapidly inactivated by the fungal enzyme as a result of cleavage of the inhibitor, primarily at the P1-P'1 reactive site. Curiously, alpha-1-antichymotrypsin was found to form complexes with Seaprose and also be inactivated by this inhibitor. Apparently, the enzyme can recognize two sites within the reactive site loop of the inhibitor, one at the P4-P'5 position, resulting in inactivation, and one presumably at the P1-P'1 reactive site which results in complex formation. The fact that Seaprose can so rapidly inactivate alpha-1-proteinase inhibitor, the primary regulator of neutrophil elastase, indicates that Seaprose would be a rather poor choice for therapy in individuals with bronchial mucus hypersecretion.
Asunto(s)
Serina Endopeptidasas/metabolismo , alfa 1-Antiquimotripsina/metabolismo , alfa 1-Antitripsina/metabolismo , alfa-Macroglobulinas/metabolismo , Secuencia de Aminoácidos , Aspergillus/enzimología , Cromatografía Líquida de Alta Presión , Electroforesis en Gel de Poliacrilamida , Humanos , Datos de Secuencia Molecular , Serina Endopeptidasas/química , Serina Endopeptidasas/farmacología , alfa 1-Antiquimotripsina/química , alfa 1-Antiquimotripsina/farmacología , alfa 1-Antitripsina/química , alfa-Macroglobulinas/química , alfa-Macroglobulinas/farmacologíaRESUMEN
Human peripheral blood monocytes isolated by centrifugation with Mono-Poly resolving medium, and human alveolar macrophages obtained by lung lavage during fiberoscopic bronchoscopy, were cultured in RPMI containing 2% foetal calf serum. The cultures were exposed to modified human proteins: alpha-1-antitrypsin cleaved with papain, fibrinogen degradation products (fraction D) purified from plasmin digest, and non-enzymatically glycosylated (glycated) serum albumin. Conditioned macrophage media were tested for the contents of acute phase cytokines by bioassay with hepatoma cells, and the concentration of interleukin-6 was determined with ELISA. Modified proteins stimulated macrophages to produce acute phase cytokines and the response was not abrogated by polymyxin B in distinction to stimulation of macrophages by endotoxin. Our data indicate that some proteolytically damaged proteins or the end glycosylation products formed in pathological states (acute inflammation, diabetes) may be responsible for the appearance of cytokines in the circulation.
Asunto(s)
Interleucina-6/biosíntesis , Macrófagos Alveolares/metabolismo , Secuencia de Aminoácidos , Animales , Ensayo de Inmunoadsorción Enzimática , Escherichia coli/metabolismo , Fibrinógeno/farmacología , Humanos , Técnicas In Vitro , Lipopolisacáridos/antagonistas & inhibidores , Lipopolisacáridos/farmacología , Neoplasias Hepáticas Experimentales/metabolismo , Datos de Secuencia Molecular , Monocitos/metabolismo , Polimixina B/farmacología , Ratas , Albúmina Sérica/química , Albúmina Sérica/farmacología , Células Tumorales Cultivadas , alfa 1-Antitripsina/farmacologíaRESUMEN
Subconfluent monolayers of human hepatoma HepG2 cells were cultured for 2 days in serum-free DMEM containing 1 microM dexamethasone and human recombinant hepatocyte growth factor (HGF), retinoic acid (RA), IL-1, IL-6, LIF and mixtures of these factors. Incorporation of labelled thymidine was significantly decreased by IL-6, IL-1 and HGF but only slightly by LIF and RA. Synthesis of acute phase proteins secreted daily to the media was measured by electroimmunoassay with monospecific antisera. In addition, the synthesis and secretion of some proteinase inhibitors (alpha-1-proteinase inhibitor, alpha-1-antichymotrypsin, C1-inactivator, plasminogen activator inhibitor-1, inter-alpha-trypsin inhibitor and pre-alpha-inhibitor) was evaluated by incorporation of labelled methionine and fluorography. Among the cytokines tested IL-6 was the most potent regulator of acute phase protein synthesis. Hepatocyte growth factor stimulated basal synthesis of alpha-1-antichymotrypsin, and to a lesser extent affected some other proteins. Retinoic acid preferentially increased synthesis of alpha-1-antichymotrypsin, ceruloplasmin and plasminogen activator inhibitor-1. Both HGF and RA slightly modulated cytokine-induced synthesis of several acute phase proteins in HepG2 cells.
Asunto(s)
Citocinas/farmacología , Factor de Crecimiento de Hepatocito/farmacología , Neoplasias Hepáticas Experimentales/metabolismo , Inhibidores de Proteasas/metabolismo , Tretinoina/farmacología , Proteínas de Fase Aguda/biosíntesis , Animales , Proteínas Sanguíneas/biosíntesis , División Celular/efectos de los fármacos , Ceruloplasmina/biosíntesis , ADN de Neoplasias/biosíntesis , Humanos , Inmunoensayo , Metionina/metabolismo , Inhibidor 1 de Activador Plasminogénico/biosíntesis , Ratas , Proteínas Recombinantes/farmacología , Radioisótopos de Azufre , Timidina/metabolismo , Células Tumorales Cultivadas , alfa 1-Antiquimotripsina/biosíntesisRESUMEN
Bovine, pig and horse leukocyte elastase inhibitors represent the first example of functionally active intracellular serpin. Sequence analysis yields data indicating that the reactive site encompasses P1-P'1 Ala-Met sequence. Oxidation of swine (as well as equine) inhibitor reduced its association rate constants kon with the tested enzymes (by at least 1 order of magnitude). However in case of bovine inhibitor, only a slight reduction has been observed for human neutrophil elastase but not for chymotrypsin or pancreatic elastase.
Asunto(s)
Neutrófilos/metabolismo , Elastasa Pancreática/antagonistas & inhibidores , Inhibidores de Serina Proteinasa/sangre , Serpinas , Secuencia de Aminoácidos , Animales , Sitios de Unión , Bovinos , Citosol/metabolismo , Caballos , Humanos , Técnicas In Vitro , Cinética , Datos de Secuencia Molecular , Inhibidores de Serina Proteinasa/química , PorcinosRESUMEN
1. Noncatalytic protein component (NPC), a strongly acidic protein (pH = 4.5) was separated from native horse leucocyte elastase 1. 2. This protein reduces elastinolytic properties of elastases: 1 and 2A probably by decreasing their isoelectric points. 3. A possible regulatory role of this protein may be inferred from a higher affinity of elastase 1 to NPC rather than to elastin.
Asunto(s)
Proteínas Sanguíneas/fisiología , Leucocitos/enzimología , Elastasa Pancreática/sangre , Animales , Electroforesis en Gel de Poliacrilamida , Caballos , Inmunoelectroforesis Bidimensional , Cinética , Elastasa Pancreática/aislamiento & purificaciónRESUMEN
Three proteinases from the azurophilic granules of horse leucocytes are typical elastases degrading elastin at neutral pH. Both proteinases: 1 and 2A exhibit similar elastinolytic activity, comparable with human leucocyte elastase (HLE). In relation to human enzyme, elastase 2B shows several-fold higher activity, which is comparable to the porcine pancreatic elastase activity (PPE). Similarly to HLE elastinolytic activity of the horse proteinases increases at higher ionic strength: twofold in case of 1 or 2A and fivefold for 2B. Significant activity observed during degradation of homologous lung elastin, implies the possible role of these enzymes during pathological injury of connective tissue in the lower respiratory tract and suggests similar pathogenesis of horse and human pulmonary emphysema.